Trevor Hallam

Trevor Hallam

Company: Sutro Bio

Job title: Chief Scientific Officer


Targeted Immunostimulants; A Promising Approach to In Situ Immunisation 9:00 am

Assess the role of immunogenic cell death in propogating more robust immune responses in patients on combination therapy with immunotherapeutics such as check-point inhibitors; a promising approach to increase durability of response Review how targeted immunostimulators now look to generate innate immune responses to tumours while increasing systemic tolerability Examine how homogeneous antibody drug conjugates…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.